Total: 1 |
|
PMID (PMCID) | ||
---|---|---|
28974385 |
FEMALE | |
Inhibition of rubella virus replication by the broad-spectrum drug nitazoxanide in cell culture and in a patient with a primary immune deficiency. | ||
Perelygina L, Hautala T, Seppanen M, Adebayo A, Sullivan KE, Icenogle J. Antiviral Res. 2017;147:58-66. |
||
Persistent rubella virus (RV) infection has been associated with various pathologies such as congenital rubella syndrome, Fuchs's uveitis, and cutaneous granulomas in patients with primary immune deficiencies (PID). |